Team:Hong Kong HKUST/hp/interview/yu

From 2013.igem.org

(Difference between revisions)
Line 71: Line 71:
{position: relative;font-size:127%;width:100%;margin:0;padding:0;padding-bottom:10px;background-color:#494042;height:1750px;}
{position: relative;font-size:127%;width:100%;margin:0;padding:0;padding-bottom:10px;background-color:#494042;height:1750px;}
#content
#content
-
{width: 995px;border:none;background-color:#ffffff;height:1700px;padding:0px;margin-top:0px;line-height: 1.5em;color: black;}
+
{width: 995px;background-color:#Ffffff;height:1700px;padding:0px;margin-top:0px;line-height: 1.5em;color: black;}
#top-section
#top-section
{height:2px;border:none;background-color:#494042;}
{height:2px;border:none;background-color:#494042;}
Line 294: Line 294:
margin-left: 20px;
margin-left: 20px;
margin-bottom: 0;}
margin-bottom: 0;}
-
#msk1{margin-left:20px;}
 
-
#msk2{margin-left:55px;}
 
-
#msk3{margin-left:35px;}
 
-
#msk4{margin-left:70px;}
 
</style>
</style>
</head>
</head>
Line 325: Line 321:
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/abstract">Abstract</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/abstract">Abstract</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/modules">Modules Description</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/modules">Modules Description</a></li>
-
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/data">Data Page</a></li>
 
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/Parts">Parts</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/Parts">Parts</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/characterization">Characterization</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/characterization">Characterization</a></li>
 +
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/modelling">Modeling</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/results">Result</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/results">Result</a></li>
-
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/future">Future Work</a></li>
 
</ul>
</ul>
</li>
</li>
Line 338: Line 333:
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/protocols">Protocols</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/protocols">Protocols</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/safety">Safety</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/safety">Safety</a></li>
-
 
+
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/future">Future Work</a></li>
</ul>
</ul>
</li>
</li>
Line 351: Line 346:
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp">Human Practice</a>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp">Human Practice</a>
<ul>
<ul>
 +
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/interview">Interviews</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/cp">Country Profile</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/cp">Country Profile</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/blog">Blog</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/blog">Blog</a></li>
-
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/interview">Interviews</a></li>
+
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/article">Article</a></li>
-
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/article/genet">Article</a></li>
+
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/video">Videos</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/video">Videos</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/presentation">Presentations</a></li>
<li><a href="https://2013.igem.org/Team:Hong_Kong_HKUST/hp/presentation">Presentations</a></li>
Line 362: Line 357:
</ul>
</ul>
 +
</div>
</div>
</div>
       <div class="row">
       <div class="row">
Line 384: Line 380:
<li>
<li>
<a href=#5>Pictures</a>
<a href=#5>Pictures</a>
-
</li><li>
 
-
<a href=#6>Download Links</a>
 
</li>
</li>
Line 459: Line 453:
<div class="nine columns"><p id="6"></p>
<div class="nine columns"><p id="6"></p>
-
<h3>Download Links</h3>
+
<h3>Downloads Link</h3>
-
<i>Right-click and click "Save link as.." on the link of items that you want to download</i>
+
<i>Right-click and click "Save Link as.." on the link of items that you want to download</i>
<br><br>
<br><br>
<a href="https://static.igem.org/mediawiki/2013/c/c8/Interview_Appendix_-_Prof._Yu.pdf">Prof. Yu's Interview Script (PDF)</a>
<a href="https://static.igem.org/mediawiki/2013/c/c8/Interview_Appendix_-_Prof._Yu.pdf">Prof. Yu's Interview Script (PDF)</a>

Revision as of 17:11, 26 September 2013



BACK TO TOP

Prof. Albert Yu

Overview

Professor Albert Yu is the chairman of the Hong Kong Biotechnology Organization (HK BIO), and also a professor of the Department of Neurobiology in Pecking University, China. As an entrepreneur and a scientist, Professor Yu gave us realistic insight of our project. Meeting Professor Albert Yu helped us to evaluate our project beyond the laboratory environment and to think about the possible future application as a biotechnology product. Towards the end of the interview, we have also talked about the bio-ethics and bio-safety issues regarding synthetic biology.

Main Discussion

Professor Yu mentioned that our project is a small step and that we have a long way to go to apply our project as commercial biotechnology product. He told us that because we are trying to insert genes into a human body, we need to be very careful with concluding how our project could be realistically applied in the future. Inserting genes into a human body can create novel metabolism that can cause side effects. Also, because the general public considers obesity less harmful, people might be reluctant to use an invasive product if they believe a less invasive means such as exercising can solve the problem. He also encouraged us to look into other plant genes that could be used to cure fatal diseases.

We have also discussed about issues on bio-safety and bio-ethics. Professor Yu said that we need to be responsible scientists and utilize the research to improve human life. He also mentioned to produce a bio-product, it is very important to consider the ethical issues of the project from the very start.

Conclusion

The interview with Professor Albert Yu helped us to have a realistic view of our project. The interview also showed that more in-depth consideration of our project’s future application is necessary if we want to see are project utilized a safe bio-product.

Interview Video



Pictures


Downloads Link

Right-click and click "Save Link as.." on the link of items that you want to download

Prof. Yu's Interview Script (PDF)

Retrieved from "http://2013.igem.org/Team:Hong_Kong_HKUST/hp/interview/yu"